paclitaxel has been researched along with Adenoma, Hepatocellular in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Choi, HG; Choi, JY; Choi, Y; Kim, J; Kwang Ku, S; Oh Kim, J; Poudal, BK; Ramasamy, T; Ruttala, HB; Soon Yong, C | 1 |
1 other study(ies) available for paclitaxel and Adenoma, Hepatocellular
Article | Year |
---|---|
Molecularly targeted co-delivery of a histone deacetylase inhibitor and paclitaxel by lipid-protein hybrid nanoparticles for synergistic combinational chemotherapy.
Topics: Adenoma, Liver Cell; Animals; Antineoplastic Agents, Phytogenic; Apoptosis; Cell Proliferation; Drug Synergism; Drug Therapy, Combination; Histone Deacetylase Inhibitors; Humans; Hydroxamic Acids; Lipids; Liver Neoplasms; Male; Mice; Mice, Inbred BALB C; Molecular Targeted Therapy; Nanoparticles; Paclitaxel; Tumor Cells, Cultured; Vorinostat; Xenograft Model Antitumor Assays | 2017 |